N-acetylaspartate is an axon-specific marker of mature white matter in vivo: A biochemical and immunohistochemical study on the rat optic nerve

Annals of Neurology

Volumn 51, Issue 1, 2002, Pages 51-58

  Bjartmar, Carl ^a   Battistuta, Jan ^a   Terada, Nobuo ^a   Dupree, Erica ^b   Trapp, Bruce D ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CLEVELAND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN; N ACETYLASPARTIC ACID; N ACETYLASPARTYLGLUTAMIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOCHEMISTRY; CONTROLLED STUDY; DISEASE MARKER; ENZYME SPECIFICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; NERVE FIBER DEGENERATION; NEWBORN; NONHUMAN; OLIGODENDROGLIA; OPTIC NERVE; PRIORITY JOURNAL; RAT; STEM CELL; WHITE MATTER;

AGE FACTORS; ANIMALS; ASPARTIC ACID; AXONS; BIOLOGICAL MARKERS; CELL DIVISION; DIPEPTIDES; IMMUNOHISTOCHEMISTRY; MALE; MYELIN PROTEINS; NERVE DEGENERATION; OLIGODENDROGLIA; OPTIC NERVE; OPTIC NERVE INJURIES; RATS; RATS, SPRAGUE-DAWLEY; STEM CELLS;

EID: 0036136536     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: 10.1002/ana.10052     Document Type: Article

References (40)

1. Axonal damage in acute multiple sclerosis lesions
2. Axonal transection in the lesions of multiple sclerosis
3. Neurological disability correlates with spinal cord axonal loss and reduced N-acetylaspartate in chronic multiple sclerosis patients
4. Putting magnetic resonance spectroscopy studies in context: Axonal damage and disability in multiple sclerosis
5. Neurodegeneration in multiple sclerosis: Relationship to neurological disability
6. Evidence for adaptive functional changes in the cerebral cortex with axonal injury from multiple sclerosis
7. Use of proton magnetic resonance spectroscopy for monitoring disease progression in multiple sclerosis
8. Serial proton magnetic resonance spectroscopic imaging, contrast-enhanced magnetic resonance imaging, and quantitative lesion volumetry in multiple sclerosis
9. Immunohistochemical localization of N-acetylaspartate in rat brain
10. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies
11. Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study
12. Axonal injury or loss in the internal capsule and motor impairment in multiple sclerosis
13. Total brain N-acetylaspartate. A new measure of disease load in MS
14. Functions of N-acetyl-L-aspartate and N-acetyl-L-aspartylglutamate in the vertebrate brain: Role in glial cell-specific signaling
15. N-acetylaspartylglutamate: The most abundant peptide neurotransmitter in the mammalian central nervous system
16. Specific expression of N-acetylaspartate in neurons, oligodendrocyte-type-2 astrocyte progenitors, and immature oligodendrocytes in vitro
17. Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types
18. In vitro expression of N-acetylaspartate by oligodendrocytes: Implications for proton magnetic resonance spectroscopy signal in vivo
19. Rat optic nerve oligodendrocytes develop in the absence of viable retinal ganglion cell axons
20. Axons modulate myelin protein messenger RNA levels during central nervous system myelination in vivo
21. Oligodendrocyte survival in Wallerian degeneration
22. Effect of optic nerve transection upon myelin protein gene expression by oligodendrocytes: Evidence for axonal influences on gene expression
23. Differentiation and death of premyelinating oligodendrocytes in developing rodent brain
24. The oligodendrocyte precursor cell in health and disease
25. NG2+ glial cells: A novel glial cell population in the adult brain
26. Proliferation and differentiation of O4+ oligodendrocytes in postnatal rat cerebellum: Analysis in unfixed tissue slices using anti-glycolipid antibodies
27. A glial progenitor cell that develops in vitro into an astrocyte or an oligodendrocyte depending on culture medium
28. Development and differentiation of glial precursor cells in the rat cerebellum
29. Chronic stage multiple sclerosis lesions contain a relatively quiescent population of oligodendrocyte precursor cells
30. Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis
31. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions
32. Reversible decreases in N-acetylaspartate after acute brain injury
33. N-acetylaspartate: A marker for neuronal loss or mitochondrial dysfunction
34. Sprouting of optic tract projections in the brain stem of the rat
35. Target size regulates calibre and myelination of sympathetic axons
36. Early N-acetylaspartate depletion is a marker of neuronal dysfunction in rats and primates chronically treated with the mitochondrial toxin 3-nitroproprionic acid
37. 1H NMR spectroscopy and high performance liquid chromatography
38. Glutamate carboxypeptidase II is expressed by astrocytes in the adult rat nervous system
39. Excitotoxic cell death
40. Selective inhibition of NAALADase, which converts NAAG to glutamate, reduces ischemic brain injury